Ambilly, France

Sêbastien Wieckowski

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Centre National De La Recherche Scientifique. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sêbastien Wieckowski. Retrieved from https://idiyas.com/inventor/sebastien-wieckowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sêbastien Wieckowski: Innovator in Drug Development

Introduction

Sêbastien Wieckowski is a notable inventor based in Ambilly, France. He has made significant contributions to the field of drug development, particularly through his innovative patent related to multimeric CD40 ligands. His work is essential in advancing therapeutic options for various medical conditions.

Latest Patents

Sêbastien Wieckowski holds a patent for "Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs." This patent describes a compound of formula (I), where Y represents a macrocycle with 9 to 36 atoms, functionalized by three amine or COOH functions. The compound includes various amino acid residues, which are crucial for its functionality in drug preparation.

Career Highlights

Sêbastien is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His role at this institution allows him to engage in cutting-edge research and development, contributing to advancements in medical science.

Collaborations

Throughout his career, Sêbastien has collaborated with esteemed colleagues such as Gilles Guichard and Sylvie Victorine Lucienne Fournel. These collaborations have further enriched his research and innovation efforts.

Conclusion

Sêbastien Wieckowski's contributions to the field of drug development through his patent on multimeric CD40 ligands exemplify his commitment to advancing medical science. His work continues to inspire future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…